# Talix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/talix

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.talix.com
- Total disclosed funding: $14M
- Latest round: Series C (Jan 8, 2016)
- Investors on record: 3

## About

Talix, Inc. is a healthcare technology company focused on enhancing clinical documentation and revenue cycle management through advanced data analytics and artificial intelligence solutions for healthcare providers.Founded in 2015 and headquartered in San Francisco, US, Talix, Inc. specializes in healthcare analytics technologies. The company was acquired by Edifecs, Inc. on September 13, 2021, an acquisition that enhanced their risk adjustment solutions. Dean Stephens leads the company as its CEO, bringing in-depth industry knowledge and expertise.Talix specializes in advanced healthcare solutions, primarily focusing on data analytics and artificial intelligence-driven software designed to optimize revenue cycle management and clinical documentation for healthcare providers. Their core offerings include a suite of products that assist hospitals and clinics in accurately capturing patient data, ensuring compliance with regulatory standards, and enhancing the overall quality of care delivered. The platform's functionalities enable end-users, including healthcare professionals and administrative staff, to streamline operations, reduce claim denials, and improve financial performance. Talix serves a diverse client base across various geographical markets, primarily in North America, where they impact the operations of hospitals, outpatient facilities, and specialty practices.Talix generates revenue through a subscription-based model, where healthcare organizations pay for access to their software solutions tailored to meet specific operational needs. The transactions typically involve annual contracts that provide clients with ongoing support, software updates, and access to analytics tools. Flagship products facilitate B2B engagements with hospitals and healthcare systems, allowing them to optimize their revenue cycles. While specific pricing structures are proprietary, clients benefit from tailored solutions that align with their operational scale and complexity, ensuring comprehensive access to Talix's tools for improving clinical documentation and financial outcomes.Following the acquisition by Edifecs, Inc., Talix plans to expand its product offerings to include enhanced risk adjustment solutions that integrate critical workflows and insights for better payer and provider collaboration. The recent funding will support these initiatives, which include plans to enter new geographical markets, particularly targeting growth in the broader North American healthcare sector. The company is poised to leverage its capabilities to establish a strong presence in these regions by the end of 2023.

## Funding rounds

- Series C, Jan 8, 2016, $14M — VantagePoint Capital, REV Venture Partners, PeakSpan Capital

## Investors

- VantagePoint Capital (https://capitalatlas.ai/funds/vantagepoint-capital) — Series C
- REV Venture Partners (https://capitalatlas.ai/funds/rev-venture-partners) — Series C
- PeakSpan Capital (https://capitalatlas.ai/funds/peakspan-capital) — Series C